NOVN Gross Margin

The Gross Margin of Novan Inc (NOVN) is 68.84%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

NOVN Gross Margin - Historical Value

Date	Value
2022-12-31	68.84%

NOVN Gross Margin - Peers Comparison

Ticker	Name	Value
PCSA	Processa Pharmaceuticals Inc	100.00%
SBBP	Strongbridge Biopharma plc	92.81%
SOL.CN	SOL Global Investments Corp	96.92%
BMY	Bristol-Myers Squibb Co	75.26%
BRCK.U.CN	BellRock Brands Inc	40.84%
CHMA	Chiasma Inc	94.59%
CLVR	Clever Leaves Holdings Inc	37.64%
ETON	Eton Pharmaceuticals Inc	60.01%
MDWD	Mediwound Ltd	13.03%
ACRX	AcelRx Pharmaceuticals Inc	-46.33%
CRDL.TO	Cardiol Therapeutics Inc	100.00%
IMCC.CN	IM Cannabis Corp	15.64%
JAGX	Jaguar Health Inc	83.27%
JNJ	Johnson & Johnson	69.11%
RPRX	Royalty Pharma PLC	7775.20%
SCPH	scPharmaceuticals Inc	68.73%
EYEN	Eyenovia Inc	-6749.02%
INLB	Item 9 Labs Corp	33.61%
ONTX	Onconova Therapeutics Inc	7775.20%
PCLO.V	Pharmacielo Ltd	20.86%
PFE	Pfizer Inc	74.33%
ADMP	Adamis Pharmaceuticals Corp	-30.10%
LLY	Eli Lilly and Co	81.31%
ROMJ.V	Rubicon Organics Inc	58.38%
SLNG.CN	Slang Worldwide Inc	52.18%
CTLT	Catalent Inc	21.75%
ELAN	Elanco Animal Health Inc	54.88%
EVFM	Evofem Biosciences Inc	80.20%
VTRS	Viatris Inc	41.65%
VREO.CN	Vireo Growth Inc	51.09%
XPHY.CN	Xphyto Therapeutics Corp	69.63%
ZTS	Zoetis Inc	70.68%
MRK	Merck & Co Inc	77.09%
NGW.CN	Next Green Wave Holdings Inc	48.77%
SCYX	SCYNEXIS Inc	100.00%